However, limited or no medical nutrition therapy (MNT) guidelines are provided to healthcare providers and patients regarding adequate nutrient intake during GLP-1RA use
A Timeline of GLP-1 Medications 1971 Jens Juul Holst from the University of Copenhagen identifies "enteroglucagon" (later named GLP-1) as a molecule that enters the bloodstream from the gut and regulates blood sugar
In medical treatments, synthetic GLP-1 medications mimic this natural hormone, offering a controlled and effective way to manage various conditions, including obesity and type 2 diabetes
Other GLP-1 and dual-agonist agents, including tirzepatide, are also in wide use, though not every GLP-1 on the market carries an FDA weight loss indication
What works better for a lot of us is spreading it out, soft, gentle protein in small bits throughout the day
The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients